Jump to content

Distributional cost-effectiveness analysis: Difference between revisions

From Wikipedia, the free encyclopedia
Content deleted Content added
Josvebot (talk | contribs)
m v1.43b - WP:WCW project (Unicode control characters)
Added some text on Extended Cost Effectiveness Analysis (ECEA)
Line 1: Line 1:
'''Distributional cost-effectiveness analysis''' ('''DCEA''') is an extension of standard [[cost-effectiveness analysis]] that incorporates concern for both the average levels of outcomes as well as the distribution of outcomes, particularly useful when evaluating interventions to tackle [[health inequality]].<ref>{{cite journal|last1=Asaria|first1=M|last2=Griffin|first2=S|last3=Cookson|first3=R|last4=Whyte|first4=S|last5=Tappenden|first5=P|title=Distributional cost-effectiveness analysis of health care programmes--a methodological case study of the UK Bowel Cancer Screening Programme.|journal=Health economics|date=June 2015|volume=24|issue=6|pages=742–54|pmid=24798212|doi=10.1002/hec.3058}}</ref><ref>{{cite journal|last1=Asaria|first1=M|last2=Griffin|first2=S|last3=Cookson|first3=R|title=Distributional Cost-Effectiveness Analysis: A Tutorial.|journal=Medical decision making : an international journal of the Society for Medical Decision Making|date=January 2016|volume=36|issue=1|pages=8–19|pmid=25908564|doi=10.1177/0272989x15583266|pmc=4853814}}</ref>
'''Distributional cost-effectiveness analysis''' ('''DCEA''') is an extension of standard [[cost-effectiveness analysis]] that incorporates concern for both the average levels of outcomes as well as the distribution of outcomes, particularly useful when evaluating interventions to tackle [[health inequality]].<ref>{{cite journal|last1=Asaria|first1=M|last2=Griffin|first2=S|last3=Cookson|first3=R|last4=Whyte|first4=S|last5=Tappenden|first5=P|title=Distributional cost-effectiveness analysis of health care programmes--a methodological case study of the UK Bowel Cancer Screening Programme.|journal=Health economics|date=June 2015|volume=24|issue=6|pages=742–54|pmid=24798212|doi=10.1002/hec.3058}}</ref><ref>{{cite journal|last1=Asaria|first1=M|last2=Griffin|first2=S|last3=Cookson|first3=R|title=Distributional Cost-Effectiveness Analysis: A Tutorial.|journal=Medical decision making : an international journal of the Society for Medical Decision Making|date=January 2016|volume=36|issue=1|pages=8–19|pmid=25908564|doi=10.1177/0272989x15583266|pmc=4853814}}</ref>

This includes Extended Cost Effectiveness Analysis which in addition to doing a standard CEA, also assesses the costs and effectiveness for different socioeconomic groups.<ref>{{Cite journal|last=Verguet|first=Stéphane|last2=Kim|first2=Jane J.|last3=Jamison|first3=Dean T.|date=2016|title=Extended Cost-Effectiveness Analysis for Health Policy Assessment: A Tutorial|url=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4980400/|journal=Pharmacoeconomics|volume=34|pages=913–923|doi=10.1007/s40273-016-0414-z|issn=1170-7690|pmc=PMC4980400|pmid=27374172}}</ref>


==References==
==References==

Revision as of 12:08, 2 October 2017

Distributional cost-effectiveness analysis (DCEA) is an extension of standard cost-effectiveness analysis that incorporates concern for both the average levels of outcomes as well as the distribution of outcomes, particularly useful when evaluating interventions to tackle health inequality.[1][2]

This includes Extended Cost Effectiveness Analysis which in addition to doing a standard CEA, also assesses the costs and effectiveness for different socioeconomic groups.[3]

References

  1. ^ Asaria, M; Griffin, S; Cookson, R; Whyte, S; Tappenden, P (June 2015). "Distributional cost-effectiveness analysis of health care programmes--a methodological case study of the UK Bowel Cancer Screening Programme". Health economics. 24 (6): 742–54. doi:10.1002/hec.3058. PMID 24798212.
  2. ^ Asaria, M; Griffin, S; Cookson, R (January 2016). "Distributional Cost-Effectiveness Analysis: A Tutorial". Medical decision making : an international journal of the Society for Medical Decision Making. 36 (1): 8–19. doi:10.1177/0272989x15583266. PMC 4853814. PMID 25908564.
  3. ^ Verguet, Stéphane; Kim, Jane J.; Jamison, Dean T. (2016). "Extended Cost-Effectiveness Analysis for Health Policy Assessment: A Tutorial". Pharmacoeconomics. 34: 913–923. doi:10.1007/s40273-016-0414-z. ISSN 1170-7690. PMC 4980400. PMID 27374172.{{cite journal}}: CS1 maint: PMC format (link)